Page 64 - AN-2-4
P. 64

Advanced Neurology                                                         Genomic insights into Alzheimer



               cases. PLoS Med, 14: e1002270.                  52.  Lindquist SG, Nielsen JE, Stokholm J, et al., 2008, Atypical
                                                                  early-onset Alzheimer’s disease caused by the Iranian APP
               https://doi.org/10.1371/journal.pmed.1002270
                                                                  mutation. J Neurol Sci, 268: 124–130.
            42.  Yoshikai S, Sasaki H, Doh-Ura K,  et al., 1990, Genomic
               organization of the human amyloid beta-protein precursor      https://doi.org/10.1016/j.jns.2007.11.021
               gene. Gene, 87: 257–263.                        53.  Edwards-Lee  T,  Ringman  JM,  Chung  J,  et al.,  2005,  An
                                                                  African American family with early-onset Alzheimer disease
               https://doi.org/10.1016/0378-1119(90)90310-n
                                                                  and an APP (T714I) mutation. Neurology, 64: 377–379.
            43.  Levy E, Carman MD, Fernandez-Madrid IJ,  et al., 1990,
               Mutation of the Alzheimer’s disease amyloid gene in      https://doi.org/10.1212/01.WNL.0000149761.70566.3E
               hereditary cerebral hemorrhage, Dutch type.  Science,   54.  Valerija D, Stefanova E, Jankovic M,  et al., 2012, Genetic
               248: 1124–1126.                                    testing in familial and young-onset Alzheimer’s disease:
                                                                  Mutation spectrum in a serbian cohort.  Neurobiol Aging,
               https://doi.org/10.1126/science.2111584
                                                                  33: 1481.e7–e12.
            44.  Wisniewski T, Ghiso J, Frangione B, 1991, Peptides
               homologous to the amyloid protein of Alzheimer’s disease      https://doi.org/10.1016/j.neurobiolaging.2011.12.007
               containing a glutamine for glutamic acid substitution have   55.  Guerreiro RJ, Baquero  M, Blesa R,  et al., 2010, Genetic
               accelerated amyloid fibril formation. Biochem Biophys Res   screening  of  Alzheimer’s  disease  genes  in  Iberian  and
               Commun, 179: 1247–1254.                            African samples yields novel mutations in presenilins and
                                                                  APP. Neurobiol Aging, 31: 725–731.
               https://doi.org/10.1016/0006-291x(91)91706-i
                                                                  https://doi.org/10.1016/j.neurobiolaging.2008.06.012
            45.  Haass  C,  Hung  AY,  Selkoe  DJ,  et al.,  1994,  Mutations
               associated with a locus for familial Alzheimer’s disease result   56.  Wang  Q, Jia  J, Qin  W,  et al., 2015, A  novel AβPP  M722K
               in alternative processing of amyloid beta-protein precursor.   mutation affects amyloid-β secretion and Tau phosphorylation
               J Biol Chem, 269: 17741–17748.                     and may cause early-onset familial Alzheimer’s disease in
                                                                  Chinese individuals. J Alzheimers Dis, 47: 157–165.
            46.  Rocchi A, Pellegrini S, Siciliano G, et al., 2003, Causative
               and susceptibility genes for Alzheimer’s disease: A review.      https://doi.org/10.3233/JAD-143231
               Brain Res Bull, 61: 1–24.
                                                               57.  Larner AJ, 2013, Presenilin-1 mutations in Alzheimer’s
               https://doi.org/10.1016/s0361-9230(03)00067-4      disease: An update on genotype-phenotype relationships.
                                                                  J Alzheimers Dis, 47: 653–659.
            47.  Kumar-Singh S, Cras P, Wang R,  et al., 2002, Dense-core
               senile plaques in the Flemish variant of Alzheimer’s disease      https://doi.org/10.3233/JAD-130746
               are vasocentric. Am J Pathol, 161: 507–520.
                                                               58.  Canevelli M, Piscopo P, Talarico G,  et al., 2014, Familial
               https://doi.org/10.1016/S0002-9440(10)64207-1      Alzheimer’s disease sustained by presenilin 2 mutations:
                                                                  Systematic  review  of  literature  and  genotype-phenotype
            48.  Castellani RJ, Honda K, Zhu X, et al., 2004, Contribution
               of  redox-active iron  and  copper  to oxidative  damage  in   correlation. Neurosci Behav Rev, 42: 170–179.
               Alzheimer disease. Ageing Res Rev, 3: 319–326.     https://doi.org/10.1016/j.neubiorev.2014.02.010
               https://doi.org/10.1016/j.arr.2004.01.002       59.  Mehrgou A, Akouchekian M, 2016, The importance of
                                                                  BRCA1 and BRCA2 genes mutations in breast cancer
            49.  Ryan NS, Biessels GJ, Kim L,  et al., 2015, Genetic
               determinants of white matter hyperintensities and amyloid   development. Med J Islam Repub Iran, 30: 369.
               angiopathy in familial Alzheimer’s disease. Neurobiol Aging,   60.  Gayther S, Warren W, Mazoyer S,  et al., 1995, Germline
               36: 3140–3151.                                     mutations of the BRCA1 gene in breast and ovarian cancer
                                                                  families provide evidence for a genotype-phenotype
               https://doi.org/10.1016/j.neurobiolaging.2015.08.026
                                                                  correlation. Nat Genet, 11: 428–433.
            50.  Ryan NS, Nicholas JM, Weston PS,  et al., 2016, Clinical
               phenotype and genetic associations in autosomal dominant      https://doi.org/10.1038/ng1295-428
               familial Alzheimer’s disease: A  case series.  Lancet Neurol,   61.  Linger RJ, Kruk PA, 2010, BRCA1  16  years later: Risk-
               15: 1326–1335.                                     associated BRCA1 mutations and their functional
                                                                  implications. FEBS J, 277: 3086–3096.
               https://doi.org/10.1016/S1474-4422(16)30193-4
                                                                  https://doi.org/10.1111/j.1742-4658.2010.07735.x
            51.  Żekanowski C, Styczyńska M, Pepłońska B,  et al., 2003,
               Mutations  in  presenilin  1,  presenilin  2  and  amyloid   62.  Hunter JC, Manandhar A, Carrasco MA,  et al., 2015,
               precursor protein genes in patients with early-onset   Biochemical and structural analysis of common cancer-
               Alzheimer’s disease in Poland. Exp Neurol, 184: 991–996.  associated KRAS mutations. Mol Cancer Res, 13: 1325–1335.
               https://doi.org/10.1016/S0014-4886(03)00384-4      https://doi.org/10.1158/1541-7786.MCR-15-0203


            Volume 2 Issue 4 (2023)                         19                        https://doi.org/10.36922/an.1734
   59   60   61   62   63   64   65   66   67   68   69